International Clinical Trial: Neoadjuvant Immunochemotherapy Combined with Surgery for Locally Advanced, Intermediate-Risk Oral Cancer: A Prospective, Multicenter, Randomized Phase III Clinical Trial Comparing Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132094) titled 'Neoadjuvant Immunochemotherapy Combined with Surgery for Locally Advanced, Intermediate-Risk Oral Cancer: A Prospective, Multicenter, Randomized Phase III Clinical Trial Comparing Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy' on Sept. 9.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Hunan Cancer Hospital

Condition: Oral Cancer

Intervention: Experimental group (postoperative concurrent chemoradiotherapy):1.Chemotherapy:Cisplatin,intravenous infusion,100mg/m2, Day 1 and Day 22 repeated every 3 weeks for 2 cycles, with a cumulative dose reaching 200m...